Researchers have completed Australia’s most detailed analysis of opioid tapering trajectories to date, with some findings that contradict current guidelines.
A new five-year study aims to build a broad picture of illicit drug use in regional Victoria, to better-understand the gaps in local health service planning.
While fentanyl is yet to markedly impact Australia, the North American opioid crisis shows us how bad it can get, and urgent action is needed now.
Changes to the Pharmaceutical Benefits Scheme have influenced the way doctors prescribe opioids, but is it for the better?
Loneliness must be regarded as a public health priority. Find out some of the surprising ways we can tackle it in Monash University’s podcast, ‘What Happens Next?’.
The hidden costs of loneliness can devastate both individuals and society. Learn about its modern roots in a new episode of Monash University's podcast, 'What Happens Next?'.
A new, long-acting formulation of the medication buprenorphine promises to improve the treatment of opioid dependence.
New rules aim to curb opioid-related deaths in Australia. These changes are a step in the right direction, but we need to tread carefully to avoid unintended consequences.
Maintaining or expanding addiction services is vital if we’re to avert a syndemic of opioid overdoses and COVID-19.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioids are among the most powerful analgesics available to medicine, but they have huge capacity to cause harm. In trying to solve one problem, is a bigger one being created?
Dummy text
